ATE62413T1 - Heilmittel gegen leishmaniose. - Google Patents

Heilmittel gegen leishmaniose.

Info

Publication number
ATE62413T1
ATE62413T1 AT87870141T AT87870141T ATE62413T1 AT E62413 T1 ATE62413 T1 AT E62413T1 AT 87870141 T AT87870141 T AT 87870141T AT 87870141 T AT87870141 T AT 87870141T AT E62413 T1 ATE62413 T1 AT E62413T1
Authority
AT
Austria
Prior art keywords
therapeutic agents
against leishmania
cure against
particles
cure
Prior art date
Application number
AT87870141T
Other languages
English (en)
Inventor
Carillo De Albornoz Anto Osuna
Santiago Castanys
Original Assignee
Sopar Sa Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sopar Sa Nv filed Critical Sopar Sa Nv
Application granted granted Critical
Publication of ATE62413T1 publication Critical patent/ATE62413T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT87870141T 1986-10-08 1987-10-08 Heilmittel gegen leishmaniose. ATE62413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8613999A FR2604903B1 (fr) 1986-10-08 1986-10-08 Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
EP87870141A EP0269598B1 (de) 1986-10-08 1987-10-08 Heilmittel gegen Leishmaniose

Publications (1)

Publication Number Publication Date
ATE62413T1 true ATE62413T1 (de) 1991-04-15

Family

ID=9339662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87870141T ATE62413T1 (de) 1986-10-08 1987-10-08 Heilmittel gegen leishmaniose.

Country Status (7)

Country Link
US (1) US4844900A (de)
EP (1) EP0269598B1 (de)
JP (1) JPS6396121A (de)
AT (1) ATE62413T1 (de)
CA (1) CA1293446C (de)
DE (2) DE3769287D1 (de)
FR (1) FR2604903B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58908194D1 (de) 1988-02-05 1994-09-22 Schering Ag Ultraschallkontrastmittel, verfahren zu deren herstellung und deren verwendung als diagnostika und therapeutika.
ATE176155T1 (de) * 1990-11-16 1999-02-15 Nippon Shinyaku Co Ltd Injizierbare amphotericin b enthaltende dispersion
CA2258744A1 (en) 1996-06-27 1997-12-31 G.D. Searle And Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
CN1733313A (zh) * 2004-08-11 2006-02-15 张阳德 聚氰基丙烯酸正丁酯纳米颗粒的制备方法
US10351644B2 (en) * 2014-02-27 2019-07-16 Shoichi Shirotake Antiviral drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186183A (en) * 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
DE2965725D1 (en) * 1978-07-19 1983-07-28 Patrick Couvreur Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
US4489055A (en) * 1978-07-19 1984-12-18 N.V. Sopar S.A. Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0269598B1 (de) 1991-04-10
FR2604903B1 (fr) 1989-01-13
US4844900A (en) 1989-07-04
FR2604903A1 (fr) 1988-04-15
EP0269598A1 (de) 1988-06-01
DE269598T1 (de) 1988-09-22
DE3769287D1 (de) 1991-05-16
JPS6396121A (ja) 1988-04-27
CA1293446C (en) 1991-12-24

Similar Documents

Publication Publication Date Title
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
ATE102043T1 (de) Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur.
IT1248557B (it) Miscele di polisaccaridi di bassi pesi molecolari, procedimento di preparazione e impiego.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
NO914114D0 (no) Fremgangsmaate for fremstilling av peroksidiske perfluorpolyetere
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2074734T3 (es) Utilizacion de composiciones a base de alcoholes grasos, para la preparacion de emulsiones; procedimiento de preparacion de emulsiones y emulsiones asi obtenidas.
DE69002767D1 (de) Fluor- und phosphorhaltige amphiphilische molekuele mit oberflaechenaktiven eigenschaften.
ATE77755T1 (de) Kontrastmittel mit stabilen, freien radikalen.
ES2061463T3 (es) Compuestos de piperidina y su preparacion y uso.
CO5140075A1 (es) Agentes terapeuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
IT1170900B (it) Agente antiallergico
DE69424362D1 (de) Verwendung von Histamin-gamma-globulin zur Herstellung eines immunomodulierenden und antiinflammatorischen Agens
PT93488A (pt) Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
DE69118978D1 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
IT1067345B (it) Procedimento per la polimerizzazione di alfa-olefine contenenti almeno 3 atomi di carbonio e catalizzatori per detto procedimento
ATE62413T1 (de) Heilmittel gegen leishmaniose.
DK1007055T3 (da) Anvendelse af amifostin
KR970074763A (ko) 불소화된 비타민 d₃ 유사체
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
PT81933B (pt) Processo para a preparacao de composicoes aperfeicoadas anti-inflamatorias contendo piroxicamo e inositol
ATE147628T1 (de) Iloprost mit wirkung gegen cerebrale malaria
IT8922246A0 (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee